NTRK2 and Alzheimer disease: TrkB.FL receptors are downregulated in the AD patient’s brain [36,37,38], while the truncated isoform of TrkB (TrkB.T1), which acts as an inhibitory modulator of BDNF signaling, is upregulated in AD [39,40].